Eventide Asset Management, LLC Sutro Biopharma, Inc. Transaction History

Eventide Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $4.82 Million - $7.95 Million	338,000 Added 14.26%	2,708,975 $40.3 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $3.91 Million - $9.23 Million	385,000 Added 19.39%	2,370,975 $51.5 Million
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $5.07 Million - $7.74 Million	700,000 Added 54.43%	1,985,975 $15.4 Million
Q1 2020 May 15, 2020	BUY	$6.19 - $12.16 $254,285 - $499,532	41,080 Added 3.3%	1,285,975 $13.1 Million
Q4 2019 Jan 29, 2020	BUY	$8.15 - $11.39 $5.87 Million - $8.2 Million	719,895 Added 137.12%	1,244,895 $13.7 Million
Q3 2019 Nov 21, 2019	SELL	$7.91 - $11.76 $5.69 Million - $8.47 Million	-719,895 Reduced 57.83%	525,000 $4.77 Million
Q3 2018 Nov 14, 2018	BUY	$15.0 - $15.2 $18.7 Million - $18.9 Million	1,244,895 New	1,244,895 $18.1 Million

136

60.9M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $106M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.